SCHEMBL8380141

SCHEMBL8380141

COc1ccc(-c2cc(OCCNC(=O)OC(C)(C)C)no2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.51
RAB9A P51151 8/20 0.51
SMN1; SMN2 Q16637 6/20 0.51
TP53 P04637 4/20 0.51
HPGD P15428 5/20 0.49
KMT2A Q03164 2/20 0.49
HDAC3 O15379 1/20 0.49
HDAC4 P56524 1/20 0.49
HDAC1 Q13547 1/20 0.49
HDAC7 Q8WUI4 1/20 0.49
HDAC2 Q92769 1/20 0.49
HDAC10 Q969S8 1/20 0.49
HDAC11 Q96DB2 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
HDAC9 Q9UKV0 1/20 0.49
HDAC5 Q9UQL6 1/20 0.49
MAPT P10636 2/20 0.48
ALDH1A1 P00352 1/20 0.47
RECQL P46063 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8378768 0.90 BCHE (0.45) NPC1RAB9ASMN1; SMN2TP53HDAC3
SCHEMBL8375551 0.89 HDAC1 (0.44) NPC1RAB9ASMN1; SMN2KMT2AHDAC3
SCHEMBL8379534 0.89 TP53 (0.47) NPC1RAB9ATP53HPGDHDAC3
SCHEMBL8375005 0.89 RAB9A (0.59) NPC1RAB9ASMN1; SMN2TP53HPGD
SCHEMBL8378917 0.89 BCHE (0.49) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL8375763 0.88 IDO1 (0.44) SMN1; SMN2TP53HDAC3HDAC4HDAC1
SCHEMBL8376903 0.88 TP53 (0.47) NPC1RAB9ASMN1; SMN2TP53KMT2A
SCHEMBL8378887 0.88 CA12 (0.45) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL8375557 0.88 BCHE (0.47) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL8378941 0.88 GABRA5 (0.46) RAB9ASMN1; SMN2KMT2AHDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 US disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 EP disclosed